normal human immunoglobulin (scig)

Poland

Drugs containing this active substance

  • XEMBIFY

    The medicine is used in adults, children, and adolescents with immunodeficiency to increase the concentration of antibodies (immunoglobulins) in the blood. It is intended for individuals with primary immunodeficiency, patients with hypogammaglobulinemia (e.g., in the course of chronic lymphocytic leukemia or multiple myeloma), and individuals following stem cell transplantation.

    Form: solution for injection, subcutaneous

    Active substance Dosage
    normal human immunoglobulin (scig) 18 to 22 %

    ATC: J06BA01

    Manufacturer: Instituto Grifols, S.A.